Form D · Biotechnology
MedShape, Inc.
Atlanta, GA · CIK 0001463845
Offering snapshot reported Aug 22, 2014 · SEC filing
- Reported sold
- $700K Offering amount: $4M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Jul 28, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$350,000 → $700,000
- Reported investors1 → 2
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 22, 2014 | Amendment | $700,000 | $350,000vs Aug 7, 2014 | 2 | SEC filing |
| Aug 7, 2014 | Initial | $350,000 | No comparison | 1 | SEC filing |
| Feb 27, 2013 | Amendment | $6,057,007 | $3,556,988vs Jun 29, 2012 | 9 | SEC filing |
| Aug 15, 2012 | Amendment | $2,540,627 | $40,608vs Jun 29, 2012 | 4 | SEC filing |
| Jun 29, 2012 | Initial | $2,500,019 | No comparison | 3 | SEC filing |
| Jul 19, 2011 | Amendment | $5,687,751 | $5,496,773vs May 12, 2011 | 18 | SEC filing |
| May 12, 2011 | Amendment | $190,978 | $65,997vs Mar 29, 2011 | 4 | SEC filing |
| Mar 29, 2011 | Initial | $124,981 | No comparison | 2 | SEC filing |
| Sep 15, 2009 | Amendment | $9,785,108 | $6,514,977vs Aug 7, 2009 | 24 | SEC filing |
| Aug 7, 2009 | Amendment | $3,270,131 | $3,120,131vs Jun 4, 2009 | 16 | SEC filing |
| Jun 4, 2009 | Initial | $150,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-222428
Source: Form D, filed Aug 22, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lutz Biedermann | Director |
| Jack R. Blair | Director |
| Becky J. Brown | Executive |
| Gregory S. Dane | Director |
| Kenneth A. Gall | Director, Executive |
| Jack C. Griffis | Executive |
| Thomas E. Hills | Director |
| Paul F. Hills | Director |
| James Kurt Jacobus | Director, Executive |
| Richard H. Leach | Executive |
| James J. Lorenzo | Executive |
| Niles Noblitt | Director |
| Douglas J. Pacaccio | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1575 Northside Drive, Nw Suite 440
Atlanta, GA, 30318
Atlanta, GA, 30318